Guangzhou Baiyunshan Pharmaceutical Holdings (00874) released its performance for the first three quarters, with a net profit attributable to shareholders of 3.31 billion yuan, an increase of 4.78% year-on-year.
Baiyunshan (00874) released its performance for the first three quarters of 2025, with the group's operating income reaching 61.606 billion yuan...
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) released its performance for the first three quarters of 2025. The group achieved operating income of 61.606 billion yuan, an increase of 4.31% year-on-year; net profit attributable to shareholders of the listed company was 3.31 billion yuan, an increase of 4.78% year-on-year; basic earnings per share were 2.036 yuan.
Related Articles
US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.
US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.
US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.
US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.
US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.
US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
